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Olfactory stimuli are detected by over 1,000 odorant
receptors in mice, with each receptor being mapped
to specific glomeruli in the olfactory bulb. The trace
amine-associated receptors (TAARs) are a small
family of evolutionarily conserved olfactory recep-
tors whose contribution to olfaction remains enig-
matic. Here, we show that a majority of the TAARs
are mapped to a discrete subset of glomeruli in the
dorsal olfactory bulb of the mouse. This TAAR
projection is distinct from the previously described
class I and class II domains, and is formed by a
sensory neuron population that is restricted to ex-
press TAAR genes prior to choice. We also show
that the dorsal TAAR glomeruli are selectively acti-
vated by amines at low concentrations. Our data
uncover a hard-wired, parallel input stream in the
main olfactory pathway that is specialized for the
detection of volatile amines.
INTRODUCTION
Information about volatile chemicals (odorants) in the environ-
ment is transduced by odorant receptors (ORs) expressed by
olfactory sensory neurons (OSNs) in the olfactory epithelium
(Buck and Axel, 1991). Each OSN expresses one allele of a single
OR gene (Chess et al., 1994; Malnic et al., 1999; Serizawa et al.,
2004). The expressed receptor dictates odorant responsiveness
(Bozza et al., 2002; Zhao et al., 1998) and influences axon guid-
ance (Feinstein and Mombaerts, 2004; Mombaerts et al., 1996;
Serizawa et al., 2006; Wang et al., 1998). OSNs expressing
a given OR send convergent axonal projections to defined
glomeruli in the main olfactory bulb (Mombaerts et al., 1996;
Ressler et al., 1994; Vassar et al., 1994), thereby mapping the
OR repertoire onto the glomerular array.
In order to detect structurally diverse odorants, mammalian
OR repertoires are typically large (Niimura, 2009; Zhang and
Firestein, 2009). Mice have over 1,000 ORs divided into two
phylogenetically distinct groups: 150 class I ORs and > 900
class II ORs (Freitag et al., 1995; Glusman et al., 2001; Zhang
and Firestein, 2002). OSNs in the dorsal epithelium express
most of the class I ORs and a subset of class II ORs (Zhang
et al., 2004; Tsuboi et al., 2006). The axons of these intermingled76 Cell Reports 2, 76–88, July 26, 2012 ª2012 The Authorspopulations segregate and form glomeruli in two discrete
domains (DI and DII) in the dorsal bulb (Bozza et al., 2009;
Kobayakawa et al., 2007; Tsuboi et al., 2006; Zhang et al.,
2004). The DI and DII domains can be observed functionally
and may play a role in representing odor quality (Bozza et al.,
2009; Kobayakawa et al., 2007; Matsumoto et al., 2010).
The trace amine-associated receptors (TAARs) were identified
as a second class of chemosensory receptors (Liberles and
Buck, 2006) that are evolutionarily conserved in vertebrates,
including humans (Lindemann et al., 2005). While this conserva-
tion suggests a critical role in olfaction, the contribution of
this small receptor repertoire to olfactory function is unknown.
The mouse has 15 TAAR genes, 14 of which are expressed in
the main olfactory epithelium (Liberles and Buck, 2006). TAARs
are phylogenetically related to biogenic amine receptors (Borow-
sky et al., 2001; Bunzow et al., 2001; Grandy, 2007) and respond
selectively to amines in heterologous systems (Ferrero et al.,
2011; Ferrero et al., 2012; Liberles and Buck, 2006; Sta¨ubert
et al., 2010; Zucchi et al., 2006). Some TAARs respond to odor-
ants that could serve as social cues and/or predator-derived
signals (Ferrero et al., 2011; Liberles and Buck, 2006). However,
nothing is known about the wiring and functional properties of
TAAR-expressing OSNs in vivo.
We used gene targeting and optical imaging to visualize and
functionally characterize TAAR projections in the mouse olfac-
tory system. We find that a majority of the TAARs are mapped
to a cluster of glomeruli located between the previously charac-
terized DI and DII domains in the dorsal olfactory bulb. The TAAR
projection is associated with a distinct subset of OSNs that is
biased to choose TAARs over other ORs, similar to the bias
observed for OSNs expressing class I and class II ORs. We
also provide evidence that this bias in gene expression is already
established prior to initial receptor gene choice. Using in vivo
optical imaging, we show that the dorsal TAAR glomeruli are
selectively activated by low concentrations of volatile amines.
Our data reveal that the TAARs feed into a genetically and
anatomically distinct olfactory input stream that is selectively
activated by volatile amines.RESULTS
We characterized the expression of all of the individual TAAR
genes in the olfactory epithelium by in situ hybridization. Ten
of the fourteen TAARs (Taar2, 3, 4, 5, 7e, 7f, 8a, 8b, 8c, and 9)
were expressed specifically in the dorsal epithelium (Figure S1)
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Figure 1. Gene Targeting Reveals TAAR
Projections to the Olfactory Bulb
(A) Top: diagram of the TAAR gene cluster. Poly-
gons indicate gene orientation; olfactory TAARs
are shown in black, nonolfactory Taar1 in white.
Expression in the dorsal or ventral epithelium is
indicated. Bottom: structure of Taar3 and Taar4
loci showing coding sequences (white boxes),
untranslated regions (black boxes) and tran-
scription start sites (arrows). Targeted insertions
contain an internal ribosome entry site (gray box
marked, ‘‘i’’) and coding sequences for fluorescent
markers (colored boxes). Black triangles indicate
the location and orientation of loxP sites.
(B1) Medial view of the olfactory epithelium in a
T4-RFP/T4-ChYFP mouse. (B2) Higher magnifi-
cation shows that OSNs are either green or red.
(B3) Detailed view of an epithelial section showing
two neighboring OSNs, each expressing one of
the two Taar4 alleles.
(C) Dorsal view of the olfactory bulbs of a hetero-
zygous T4-RFP mouse showing axonal projec-
tions and glomeruli formed by tagged OSNs.
(D) Dorsal view of the bulbs of a heterozygous
T4-ChYFP mouse.
(E) Highmagnification image of a lateral glomerulus
in a compound heterozygous T4-RFP/T4-ChYFP
mouse. Axons coalesce into the same glomerulus.
(F) Dorsal view of the bulbs of a heterozygous T3-
YFP mouse.
(G) Dorsal view of the bulbs of a double hetero-
zygous T3-YFP/T4-RFP mouse. Boxed area is
shown in (H).
(H) Higher magnification image of lateral glomeruli
in T3-YFP/T4-RFP mice.
(I) Right olfactory bulbs from three T4-RFP mice
illustrating different patterns of glomerular con-
vergence by T4 axons. The arrowhead points to
a ‘‘fused’’ glomerulus (receiving both lateral and
medial innervation). Anterior and medial are indi-
cated.
(J) Positions of medial (red circles), lateral (blue
circles), and ‘‘fused’’ glomeruli (green squares)
taken from the left and right olfactory bulb across
animals (n = 62 bulbs; ages P15 to P75).
Glomerular positions were measured with respect
to the length and width of the bulbs and projected
onto a bulb of average size. Scale bar represents
200 mm in (B1); 65 mm in (B2); 20 mm in (B3);
350 mm in (C), (D), (F), and (G); 90 mm in (E); 80 mm
in (H); and 250 mm in (I).
See also Figures S1 and S2.and are referred to here as ‘‘dorsal TAARs.’’ In contrast, Taar7a
and 7b were expressed predominantly in the ventral epithelium,
named here as ‘‘ventral’’ TAARs. Taar6 and 7dwere expressed in
both zones, described here as ‘‘broad TAARs.’’ Thus, a majority
of TAARs are expressed in the dorsal epithelium, which sug-
gested to us that they might project to glomeruli in the dorsal
olfactory bulb.
TAAR-Expressing OSNs Project to Glomeruli in the
Dorsal Olfactory Bulb
To directly visualize TAAR-expressing OSNs and their projec-
tions, we modified two dorsal TAAR genes, Taar3 (T3) andTaar4 (T4), through gene targeting to drive coexpression of
fluorescent markers tauVenus (YFP), tauCherry (RFP), or chan-
nelrhodopsin2-YFP (ChYFP). We generated three strains of
gene-targeted mice: T3-YFP, T4-RFP, and T4-ChYFP (Fig-
ure 1A). Each strain exhibited spatially distributed subsets of
labeled OSNs in the dorsal epithelium (Figure 1B). In mice
harboring alternately tagged T4 alleles, we found no double-
labeled cells (n = 2,588 OSNs; Figure 1B), indicating that TAARs
are subject to monoallelic expression, like classical ORs.
OSNs expressing T3 and T4 project to glomeruli in the dorsal
aspect of the main olfactory bulb (Figures 1C–1H). T3 and T4 ax-
ons form neighboring but distinct glomeruli (Figures 1G and 1H).Cell Reports 2, 76–88, July 26, 2012 ª2012 The Authors 77
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Figure 2. T4 Glomeruli Lie Outside DII and Are Closely Associated
with DI
(A) Medial view of the olfactory epithelium showing overlapping distribution of
DS50 (class I) and DM72 (class II) OSNs in the dorsal epithelium.
(B) Dorsal view of the olfactory bulbs in whichDS50 andDM72 axons innervate
DI (yellow) and DII (red).
(C) Dorsal view of the bulbs of a P-LacZ Tg+ ; T4-ChYFP heterozygous mouse
showingDII axons (red) and T4 glomeruli (green). T4 glomeruli fall outside of DII.
(D) Coronal section through the bulb of a P-LacZ Tg+ ; T4-ChYFP heterozy-
gous mouse showing a T4 glomerulus (green) in the LacZ-negative region. The
boundary between this region and DII (red) is indicated by arrowheads. Nuclei
are stained with TOPRO-3 (blue).
(E) Dorsal view of the bulbs of a DS50-YFP ; T4-RFP double heterozygous
mouse showing the DI axons (yellow) and T4 glomeruli (red).
(F) Coronal section showing absence of innervation of the T4 glomerulus (red)
by DS50-YFP axons (yellow), counterstained with TOPRO-3 (blue).
Scale bar represents 260 mm in (A); 500 mm in (B), (C), and (E); 130 mm in (D);
and 30 mm in (F).Axons from OSNs expressing the genetically tagged
alleles intermingle with unlabeled axons in heterozygous mice,
but not in homozygous mice (Figure S2), suggesting that the
genetically tagged axons exhibit normal targeting with corre-78 Cell Reports 2, 76–88, July 26, 2012 ª2012 The Authorssponding wild-type axons (Bozza et al., 2002; Vassalli et al.,
2002). In addition, T4 axons expressing RFP or ChYFP coinner-
vated the same glomeruli (Figure 1E), indicating that the markers
do not differentially affect axon guidance.
As with canonical ORs (Mombaerts et al., 1996), T3 and T4
axons have medial and lateral projections to each bulb (Figures
1C and 1F). However, we note several characteristic features of
TAAR projections. First, the medial and lateral glomeruli are
closer to each other than is typically observed for dorsal
ORs: T4 glomeruli were separated by 491 mmonaverage (range=
306–666 mm, n = 23 bulbs). By comparison, glomeruli for class I
projections are typically separated by roughly 700–1,000 mm
(data not shown). Second, in T4-RFP mice, 6 out of 62 bulbs
had a glomerulus that received input from both medial and
lateral axons. These ‘‘fused’’ glomeruli were usually located
between the medial and lateral convergence sites (Figure 1I).
Third, the incidence of supernumerary glomeruli (>2 per bulb)
was higher for T4 than for other ORs; the average number of
glomeruli per bulb was 2.5 ± 0.5 (mean ± SD; 1.1 ± 0.3 medial,
1.3 ± 0.5 lateral, 0.1 ± 0.2 fused; n = 66 bulbs) in mice ranging
from P15 to P75. No difference was observed at P15, P30,
P45, P60, or P75 (data not shown). Despite this overall variability,
T4 glomeruli were restricted to a circumscribed region of the
caudal bulb (Figure 1J). Similar projection patterns were seen
for Taar5 and Taar9 in gene-targeted mice (data not shown),
suggesting that the dorsal TAARsmight map to a discrete caudal
region on the dorsal bulb.
TAAR-Expressing OSNs Form a Third Dorsal
Projection, DIII
The dorsal bulb has been previously divided into two known
projections or domains: DI and DII (Figures 2A and 2B). To
examine whether TAAR-expressing OSNs project to the DI or
DII domains, we crossed T4-ChYFP mice with the transgenic
marker P-LacZ (Figure 2C), which drives b-galactosidase
expression in a large proportion of class II-expressing OSNs
and labels DII (Bozza et al., 2009; Vassalli et al., 2011). In these
mice, T4 glomeruli were located in the LacZ-negative region,
medial to DII (Figures 2C and 2D). We also crossed T4-RFP
mice to DS50-YFP animals, in which the DI domain is labeled.
In these mice, T4 glomeruli were located near the caudal margin
of DI (Figures 2E and 2F), often partially intermingled with YFP-
labeled, class I glomeruli. Despite being closely associated
with DI, significantly fewer T4 glomeruli were innervated by
DS50 axons than glomeruli for a model class I OR, MOL2.3
(data not shown). This suggested that T4 glomeruli have
a different axon guidance identity than DI glomeruli.
If TAAR glomeruli are part of the DI projection, then TAAR-
deletion alleles should diffusely label the entire DI domain, as is
seen for class I OR deletions (Bozza et al., 2009). To test this,
we generated three gene-targeted mouse strains with TAAR
coding-sequence deletions:DT4-YFP, in which the Taar4 coding
sequence is replaced with Venus YFP; DT4-RFP, in which the
Taar4 coding sequence is replaced with gap-cherry; and DT9-
CFP, in which the Taar9 coding sequence is replaced with
Cerulean CFP (Figure 3A). Strikingly, OSNs expressing these
TAAR-deletion alleles densely innervate a small cluster of
glomeruli in the dorsal bulb (Figures 3B and 3C). The cluster
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Figure 3. TAAR Coding Sequence Deletions
Reveal a Third Domain
(A) Gene targeting performed to generate three
TAAR-deletion alleles. Noncoding regions are
shown as black boxes, transcription start sites as
arrows. The coding sequence (white box) of Taar4
is replaced with either Venus YFP (green) or gap-
Cherry (red); Taar9 is replaced with Cerulean CFP.
LoxP sites are shown as black triangles.
(B) Dorsal view of the olfactory bulbs of a hetero-
zygous DT4-YFP mouse showing a cluster of
glomeruli (green) located in the caudal bulb.
(C) Dorsal view of the bulbs of a homozygous DT9-
CFP mouse.
(D) Dorsal view of the bulbs of a P-LacZ Tg+ ;
DT4-YFP heterozygous mouse. The axons and
glomeruli labeled by DT4-YFP axons (green) are
located outside of the DII domain (red).
(E) Dorsal view of the bulbs of a DS50-YFP ; DT4-
RFP double heterozygous mouse showing that the
glomeruli labeled by the DT4-RFP allele (red) are
distinct from DI (yellow).
(F) Dorsal view of the bulbs of a P-LacZ Tg+ ;DS50-
YFP ; DT9-CFP triple mutant mouse showing
that the region labeled by theDT9-CFP allele (cyan)
is largely separate from DI (yellow) and DII (red).
(G) Coronal section through the bulb of a P-LacZ
Tg+ ; DS50-YFP ; DT9-CFP triple mutant mouse
showing that DT9 axons (cyan) are outside of DI
(yellow) and DII (red). DII glomeruli are densely
innervated by LacZ-positive axons (red). (G2)
Higher magnification view of the area indicated
in (G1).
Scale bar represents 500 mm in (B–F), 120 mm in
(G1), and 80 mm in (G2).comprised 19 ± 3 glomeruli (mean ± SD; n = 8 bulbs) in hetero-
zygous DT4-YFP mice. This pattern is in stark contrast to
class I and class II OR deletions, which exhibit sparse labeling
of a large number of glomeruli (Figure 2B; Bozza et al., 2009).
When crossed to the class I and class II markers, the DT4- and
DT9-labeled glomeruli were distinct from DI and DII glomeruli
(Figures 3D–3G). Thus, the TAAR-deletion alleles reveal another
dorsal projection, named here as DIII, that appears distinct from
DI and DII.TAAR-Expressing OSNs Are Biased to Coexpress
TAAR Genes
The DI and DII projections are generated by two types of OSNs
(d1 and d2) that selectively express class I or class II genes,
respectively (Bozza et al., 2009). The dense labeling of relatively
few glomeruli by DT4-OSNs is consistent with the idea that
they also exhibit biased coexpression from a limited repertoire
of OR genes—perhaps the TAARs. To test this, we quantified
coexpression in DT4-YFP OSNs by combined immunohisto-
chemistry and in situ hybridization, using equally sized class-
specific probe mixes (Figures 4A and 4B). Indeed, DT4-YFP
OSNs were much more likely to be labeled by the TAAR mix
than the class I or class II mixes (TAAR = 37%, 47/128 cells; class
I = 0.3%, 1/313 cells; class II: 0/320 cells; Fisher’s exact test,
p < 0.001; Figure 4C). Because we observed low levels of classI OR expression, we tested 37 individual class I OR probes. The
data show that class I coexpression occurs rarely (Figure 4E).
If TAARs are selectively expressed by a third OSN type, then
d1 and d2 OSNs should not coexpress the TAAR genes. To
test this prediction, we quantified TAAR coexpression in DS50-
YFP (class I) and DM72-GFP (class II) OSNs by using a probe
mix that hybridizes to all 14 olfactory TAARs (Figure 4D). As
predicted, we observed very low levels of coexpression (or no
coexpression) of TAARs in class I and class II OR-deletion
neurons (1/609 DS50-OSNs; 0/644 DM72-OSNs). In contrast,
a large proportion of DT4-YFP OSNs was labeled by the same
TAAR probe mix (64.5%, 371/575 DT4 OSNs; Fisher’s exact
test, p < 0.001). We note that this is less than the 100% that
one might predict (see Discussion). Overall, these data indicate
that the d1 and d2 OSNs are strongly biased against expressing
TAAR genes, consistent with the idea that TAARs are chosen
selectively by a specific OSN type (d3).
Using gene-specific probes, we observed thatDT4-YFPOSNs
selectively coexpress the dorsal TAARs (Taar2, 3, 4, 5, 7e, 7f, 8a,
8b, 8c, and 9). Coexpression rates ranged from 1.9% to 13.7%
(Figure 4F). This is up to 20-fold higher than rates observed
for OR coexpression in class I and class II OR deletions (Bozza
et al., 2009), further suggesting that DT4-OSNs choose from
a smaller repertoire of potential alleles. Coexpression of the
ventral and broad TAARs, however, was either infrequent or
not observed. This most likely reflects the normal paucity (orCell Reports 2, 76–88, July 26, 2012 ª2012 The Authors 79
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Figure 4. DT4-YFP OSNs Selectively Coexpress
TAARs
(A) Schematic of gene choice in DT4-OSNs. A nascent
OSN (gray) chooses the DT4 allele (yellow box) and is
labeled (yellow cell), does not express a functional
receptor (gray cilia), and makes an alternate choice
(dashed arrows).
(B) Epithelial section from a DT4-YFP mouse. OSNs ex-
pressing the DT4-YFP allele are labeled (green) by immu-
nohistochemistry for YFP; TAAR-expressing OSNs are
labeled (red) by in situ hybridization using a TAAR probe
mix. Double-labeled OSNs (yellow) coexpress DT4-YFP
and a dorsal TAAR gene. Scale bar represents 20 mm.
(C) Coexpression rates for class I ORs, class II ORs, and
TAARs in DT4-OSNs. Each class is represented by
a mixture of 5 dorsally expressed probes (see Experi-
mental Procedures).
(D) Coexpression rates for TAARs in class I OR-, class II
OR-, and TAAR-deletion OSNs (DS50, DM72, and DT4)
using the probe mix for all TAARs. The higher coex-
pression rate for DT4 compared with (C) is expected given
that this probe mix includes all 14 TAAR genes.
(E) Coexpression rates for 37 individual OR probes and
a Taar5 probe in DT4-OSNs.
(F) Coexpression rates for individual TAAR genes in DT4
OSNs. Coexpression was observed for all dorsal TAARs.
Coexpression of ventral/broad TAAR genes was rare. The
rate for Taar4 (gray bar) was measured in heterozygous
(DT4-YFP/wt) mice, which retain one intact copy of Taar4.
All data are pooled from counts using at least two animals.
See also Figures S1 and S3.absence) of expression of these genes in the dorsal epithelium
(Figure S1), whereDT4-OSNs are located. Thus, as a population,
DT4-OSNs are biased to coexpress the ten dorsal TAAR genes.
OSNs expressing deletion alleles project to glomeruli corre-
sponding to the coexpressedOR (Feinstein et al., 2004; Lewcock
and Reed, 2004). Similarly, we observe that DT4-YFP OSNs that80 Cell Reports 2, 76–88, July 26, 2012 ª2012 The Authorscoexpress the T4-RFP allele innervate T4-RFP
glomeruli (Figure S3). Thus, it is likely that the
glomeruli revealed in DT4-YFPmice correspond
to all ten of the dorsal TAAR genes.
Biased Coexpression of TAARs
Is Not a Cluster Effect
All of the TAAR genes are located in a single
cluster on chromosome 10. Thus, biased coex-
pression could be caused by preferential choice
of genes incis to thedeletion allele (Lewcockand
Reed, 2004) rather than by the presence of
a biased OSN type. Therefore, we investigated
the contribution of cis coexpression to the
TAAR coexpression bias. To do this, we gener-
ated a TAAR cluster deletion allele (DT2-9) in
which a 250 kb genomic interval encompass-
ing Taar2 through Taar9was excised (Figure 5A;
see also Extended Experimental Procedures).
We then crossed DT2-9 to the DT4-YFP strain,
thereby removing all of the olfactory TAARgenes
that are in trans to the DT4-YFP allele.The absence of the trans TAAR cluster had a dramatic effect
on the population ofDT4-YFPOSNs. First, the number of labeled
DT4-OSNs was reduced and the dense labeling of spatially
circumscribed TAAR glomeruli was eliminated (Figures 5B–5E).
Second, the rate of TAAR coexpression was decreased (DT4-
YFP/wt: 64%; DT4-YFP/DT2-9: 12%; Fisher’s exact test,
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Figure 5. Biased TAAR Coexpression Is Not a Cluster Effect
(A) In vivo recombination strategy to generate the TAAR cluster deletion allele.
Black polygons show location and orientation of olfactory TAAR genes.
Nonolfactory Taar1 is shown in white. Two targeted mutations, aT1-YFP and
S50/T9-CFP, introduce loxP sites (red triangles) into both ends of the cluster.
When crossed in the presence of HPRT-Cre, F1 mice harboring the cluster
deletion, DT2-9, can be recovered. S50 coding sequence shown as gray
polygon, CFP as cyan box, YFP as yellow box. Both fluorescent markers and
all olfactory TAAR genes are absent from the DT2-9 allele.
(B) Medial views of the olfactory epithelium from a control DT4-YFP/wt (B1)
mouse and a DT4-YFP/DT2-9 littermate (B2). OSNs expressing the DT4-YFP
allele can be seen in the dorsal epithelium (green). There is a decrease in the
number of OSNs expressing the DT4-YFP allele in the absence of trans co-
expression. Both images were scanned using the same gain settings. Blue is
background autofluorescence.
(C) Dorsal views of olfactory bulbs from control DT4-YFP/wt (C1) and DT4-
YFP/DT2-9 littermate (C2) mice. The pattern of intensely labeled glomeruli
(green) normally seen (C1) is severely reduced in the absence of trans coex-
pression (C2). Both images were scanned using the same settings.
(D) High-magnification image of the same bulbs in (C). The image (D2) was
scanned at higher gain.
(E) Coronal sections of glomeruli in DT4-YFP/wt (E1) and a DT4-YFP/
DT2-9 (E2).
Glomeruli in DIII are densely innervated by DT4-YFP axons in DT4-YFP/wt
mice.
Only sparse innervation is seen in the absence of the trans cluster. Sections are
counterstained with the nuclear label TOPRO-3 (blue).
(F) Coexpression rates for all TAARs in DT4 -OSNs, in the presence (DT4/wt) or
absence (DT4-YFP/DT2-9) of the wild-type TAAR cluster in trans. Coex-
pression is drastically reduced when the choice of TAAR alleles in trans is no
longer available.
(G) Coexpression rates for TAAR genes in DT4-OSNs when the trans cluster is
absent (only alleles in cis are available). Coexpression is biased toward the
genes immediately flanking the DT4-YFP allele. T7 and T8 indicate coding-
sequence probes for Taar7a and Taar8b, which hybridize to all members of
their respective subfamilies.
Scale bar represents 200 mm in (B) and (D), 400 mm in (C), and 30 mm in (E).p < 0.0001; Figure 5F), suggesting that coexpression in cis does
not readily occur, or is not readily detectable. Finally, the rare
coexpression that did occur in cis was observed only for the
genes immediately flanking the DT4-YFP locus—Taar3 and
Taar5 (Figure 5G). This positional bias in coexpression is not
observed in the presence of the trans cluster (Figure 4F). Taken
together, the data indicate that coexpression in DT4-OSNs
occurs preferentially in trans and that a cluster effect cannot
account for the gene expression bias that we observed. Rather,
we propose that the bias in gene choice is an inherent property
of the OSNs that choose from the TAAR repertoire.
TAAR-Expressing OSNs Show Biased ‘‘First’’ Choice
A hallmark of our model is that different OSN types exhibit
biased gene choice. However, we have observed biases only
in alternate choice (i.e., coexpression in OSNs that have first
chosen an OR-deletion locus). It has not been possible to
observe biases in first choice. Taking advantage of the small
TAAR gene family, we looked for evidence of biased first choice
by examining the effect of gene dosage on the probability
of TAAR gene expression (Figure 6A). Aside from TAARs, it is
estimated that 400 OR genes are expressed in the dorsal epithe-
lium (Zhang et al., 2004). If each dorsal OSN initially chooses from
all dorsal genes (i.e., there are no OSN types), then removing oneCell Reports 2, 76–88, July 26, 2012 ª2012 The Authors 81
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Figure 6. Reducing the Number of TAAR Alleles Increases the Probability of T4-RFP Expression
(A) Diagram of the hypothesis that there is a population of fixed size, d3-OSNs (gray neurons), that is restricted to choose among the TAAR alleles. Left: in the
presence of both copies of the TAAR cluster, each individual allele, i, has a specific probability of expression, pi. In heterozygous T4-RFP animals, a subset of
d3-OSNs express the tagged allele as dictated by its probability, pT4. Right: in the absence of the trans cluster (i.e. half the number of available TAAR alleles),
the probability of choosing the remaining Taar4 allele (T4-RFP) and the number of RFP-labeled OSNs in the epithelium would double. If OSNs can choose among
all 800 dorsal OR alleles (400 genes), the loss of 14 alleles should have a negligible effect on choice probability.
(B) Whole-mount views of the olfactory epithelia in T4-RFP/wt and T4-RFP/DT2-9 mice. Insets show higher magnification. Scale bar represents 400 mm, 50 mm
in insets.
(C) Normalized counts of RFP-labeled OSNs in epithelial sections of T4-RFP/wt, and T4-RFP/DT2-9 mice. The number of T4-RFP OSNs was normalized to
a dorsal class II population, M72-GFP, in the same sections. The number of OSNs expressing the T4-RFP allele nearly doubles in the absence of the trans TAAR
cluster (error bars show SD). Data represent mean ± SD.copy of the TAAR cluster (14 out of800 available alleles) would
have a negligible effect on the number of OSNs expressing any of
the remaining TAAR alleles. On the other hand, if there were
a fixed population of OSNs restricted to express TAARs (i.e.,
a d3 OSN type), removing one copy of the TAAR cluster (14 out
of 28 available alleles) should double the number of OSNs that
express any of the remaining TAAR alleles (Figure 6A).
To distinguish between these possibilities, we compared the
number of OSNs expressing the T4-RFP allele in the presence or
absence of the trans TAAR cluster. Indeed, the number of T4-RFP82 Cell Reports 2, 76–88, July 26, 2012 ª2012 The AuthorsOSNs nearly doubled when the repertoire of available TAAR
alleles was reduced by half (1.9- ± 0.1-fold increase; mean ± SD;
n = 4 mice per genotype; Figures 6B and 6C). Similar data were
obtained for T3 (data not shown). Our interpretation is that there
is a fixed population of neurons (an OSN type) that is restricted
to choosing from the TAAR repertoire prior to first choice.
Taken together, our anatomical and genetic data demonstrate
that the DT4 mutation marks a third OSN type, d3, which
creates a third dorsal projection, DIII, comprising glomeruli
corresponding to all of the dorsally expressed TAAR genes.
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Figure 7. The Dorsal TAAR Glomeruli Are Selec-
tively Activated by Amines
(A) In vivo glomerular imaging in a DT4-YFP heterozygous
mouse. Top left: resting spH fluorescence imaged through
thinned bone. Pseudocolored panels show odor-evoked
changes in fluorescence (DF) in response to the indicated
odorants. All panels are scaled to the same maximum DF.
Dotted line approximates the edges of the left and right
olfactory bulbs. Anterior is up.
(B) Left panel: same mouse as in (A) showing YFP-labeled
glomeruli (outlined in magenta). Pseudocolored images
show maximum response projections for amine and
nonamine odorants. Panel marked ‘‘amines-YFP’’ shows
max amines responses with the outlined YFP-labeled
regionmasked. Only small responses lateral to DIII remain.
(Blood vessel-derived intrinsic signals can be seen in left
anterior bulb). Amine responses include the amines in (A)
plus 0.005% trimethylamine, 0.01% N-methylpiperidine,
0.01% triethylamine, 0.01% cyclohexylamine, 0.01%
octylamine, and 1% ethylenediamine. Nonamine odors
include 1% propyl acetate, phenetole, isopropyl tiglate,
2-heptanone, and propionic acid.
(C) Maximum response projections in two other mice
showing clustering of amine-responsive glomeruli.
Responses are scaled from 0%–95% of the maximum
DF within a given animal. Amine odors: 0.01% b-phenyl-
ethylamine, 0.001% isopentylamine, 0.005% trimethyl-
amine, 0.01% N-methylpiperidine (mouse 1), plus 0.01%
cyclohexylamine (mouse 2).
(D) Odorant responses in another DT4-YFP heterozygous
mouse overlaid onto the YFP signal. Greyscale image
shows YFP-labeled projections in the left and right bulbs.
Outline of midline and caudal bulb is indicated (dotted
line). Response maps were thresholded at 16%maximum
DF, pseudocolored and overlaid on top of the greyscale
image. Responses to different amines are confined to
YFP-labeled glomeruli. Lower right panel shows thresh-
olded maximum projections indicating the locations of
glomeruli responding to four amines—cadaverine, trime-
thylamine, b-phenylethylamine, and cyclohexylamine.
A broadly tuned, b-phenylethylamine-responsive glomer-
ulus appears white in overlay. Odor responses are
scaled from 0% to 95% of the maximum DF for a given
odorant presentation.
(E) Response profiles of DIII (YFP-positive) glomeruli to
a set of six odorants: CAD, 1% cadaverine; CHX, 0.001%
cyclohexylamine; IPA, 0.001% isopentylamine; NMP,
0.01% N-methylpiperidine; PEA, 0.01% b-phenylethyl-
amine; TMA, 0.005% trimethylamine. The area of each
dot is proportional to response amplitude (DF). Response
profiles are ordered by hierarchical clustering (Ward’s
method) with groups indicated (colored shading).The DIII Glomeruli Form an Amine-Selective Domain
The TAARs respond preferentially to amines in heterologous
expression systems (Liberles andBuck, 2006). However, nothingCell Repois known about the function of the olfactory
TAARs in vivo. To examine their functional prop-
erties, we imaged odor-evoked activity from the
olfactory bulbs of mice expressing the geneti-
cally encoded activity reporter synaptopHluorin
in all mature OSNs (Bozza et al., 2004). By
recording from mice that were also heterozy-gous for the DT4-YFP allele, we could directly visualize the DIII
glomeruli (including T4). We asked whether amines preferentially
activate the DIII glomeruli by using the lowest concentration ofrts 2, 76–88, July 26, 2012 ª2012 The Authors 83
amines that elicited robust responses across animals (deter-
mined experimentally).
Surprisingly, we found that low concentrations of amines
selectively activated a few highly sensitive glomeruli clustered
in the dorsal, caudal bulb (Figure 7A). The cluster of amine-selec-
tive glomeruli was observed across animals (Figure 7C; n = 11
wild-type or DT4-YFPmice) and corresponded to the genetically
tagged DIII projection (Figures 7A and 7B). DIII glomeruli were
the most sensitive amine-responsive glomeruli in the dorsal
bulb. Although some amines activated glomeruli outside of
DIII, these responses were always much smaller in amplitude
(Figure 7B). Within DIII, the amines were represented in a combi-
natorial fashion, each eliciting responses in one or a few
glomeruli (Figure 7D). Across animals, we were able to identify
up to 12 amine-responsive glomeruli per bulb (n = 6 mice), sug-
gesting that our odorant set activates a subset of the20 dorsal
TAAR glomeruli. The response profiles of DIII glomeruli could be
classified into seven groups with variable breadth of tuning (Fig-
ure 7E; n = 3mice). Themost effective stimulus was b-phenyleth-
ylamine, which elicited the largest amplitude responses despite
being presented at the lowest vapor concentration. Imaging
experiments in T4-RFP mice show that these b-phenylethyl-
amine-responsive glomeruli correspond to T4 (R.P., A.D.,
J. Zhang, and T.B., unpublished data).
Taken together, the data demonstrate that the DIII projection
represents glomeruli for the dorsally expressed TAARs and
that these glomeruli are the most sensitive amine-responsive
glomeruli in the dorsal olfactory bulb.
DISCUSSION
Our data reveal the anatomy and functional properties of TAAR
projections to the olfactory bulb and argue strongly that 10 out
of 14 olfactory TAARs are mapped to a cluster of typical
glomeruli in the dorsal olfactory bulb of the mouse. We show
this directly for T3 and T4, and indirectly for other TAARs by
analyzing TAAR-deletion alleles. We provide genetic evidence
that the OSNs that form this projection are restricted to express
TAAR genes prior to initial choice and are different from those
underlying the previously described DI and DII domains. There-
fore, we refer to the TAAR projection as ‘‘DIII.’’ We go on to
show that the DIII projection comprises highly sensitive, amine-
responsive glomeruli, establishing an amine-selective, functional
domain in the dorsal bulb. Thus, the TAARs feed into a genetically
and anatomically distinct olfactory subsystem that is selectively
activated by volatile amines.
A TAAR-Specific OSN Type
Our data place the TAARs firmly into an existing framework
(Figure S4) describing the mapping of OR inputs to the olfactory
bulb by distinct types of OSNs (Bozza et al., 2009). Several lines
of evidence support the view that there is an OSN type corre-
sponding to the dorsal TAARs. First, we observe a strong bias
in gene choice—OSNs expressing a TAAR-deletion allele pre-
ferentially coexpress TAARs over class I and class II ORs, and
OSNs expressing class I and class II OR-deletion alleles rarely
coexpress the TAAR genes. Second, the gene choice bias is
not a cluster effect (i.e., a byproduct of choosing neighboring84 Cell Reports 2, 76–88, July 26, 2012 ª2012 The AuthorsTAAR genes in cis). Under our experimental conditions, coex-
pression in cis appears to be disfavored and cannot account
for the high frequency of TAAR coexpression that we observe
in DT4-OSNs. Third, this bias is not a consequence of having
already chosen a TAAR gene. Removing half of the available
TAAR alleles causes an approximate doubling of the number of
OSNs expressing one of the remaining alleles, indicating a bias
in ‘‘first choice.’’ This provides the strongest evidence to date
for the existence of intermingled OSN types, one of which is
dedicated to expressing TAARs.
One might predict that 100% of DT4-OSNs should coexpress
TAARs. Our in situ hybridization experiments show that 65%
of DT4-OSNs hybridize with a mix of probes of all the TAARs.
Similarly, the sum of coexpression rates from individual TAAR
probes is 72%. We note that it is unknown what proportion of
OSNs goes on to successfully choose an intact gene after
choosing a nonfunctional OR or TAAR—some may fail to
successfully express another receptor altogether. Consistent
with this idea, the number of labeled OSNs in DT4-YFP mice is
only 43% of the number of T4-RFP OSNs, and 30% of DT4-
OSNs are immature (OMP-negative) as compared with 9% of
T4-RFP OSNs (data not shown) —this suggests that expression
of the DT4 allele has an effect on OR maturation.
Alternatively, DT4-OSNs could choose (non-TAAR) OR genes,
in one of the two following scenarios. In the first, 35% of DT4-
OSNs could choose randomly from among the 400 dorsal
OR genes. In fact, we detected some class I OR coexpression,
but this is at relatively low rates. The doubling of T4-OSNs in
the cluster deletion argues that TAAR-expressing OSNs choose
from a small gene repertoire, suggesting that non-TAAR expres-
sion is generally a rare event. We note also that if DT4-OSNs
coexpress many OR genes, they must not form corresponding
glomeruli, as there are only 20 labeled glomeruli in DT4-YFP
mice. Thus, such hypothetical OR expression would appear to
be functionally irrelevant.
In the second scenario, the 35% of DT4-OSNs could choose
from a few specific OR genes. Our results also argue against
this. If TAAR-expressing OSNs can choose from a few, specific
OR genes, these genes should still be available for coexpression
in DT4-YFP/DT2-9 mice. In this case, we would not likely see
the dramatic reduction in DT4 cell number, and we would expect
to see a few densely innervated glomeruli in these animals. We
do not observe this. Taken together, the data suggest that
the lower-than-expected coexpression rate of TAARs may be
partly explained by DT4-OSNs that have not yet initiated tran-
scription of another TAAR (at least in detectable amounts) or
that have failed to choose another receptor.
The underlying cause of the reduction in cell number and axon
labeling in DT4-YFP/DT2-9 mice is not known. Coexpression in
cis might be disfavored, leading to cell death. Alternatively,
DT4-OSNs might switch in cis to a neighboring TAAR gene,
silencing the DT4-YFP allele. The rare labeled OSNs that we
observe in DT4-YFP/DT2-9 mice could represent those that
have switched to express a TAAR allele in cis, have terminated
transcription of the deletion allele, but still retained enough
YFP protein to be labeled. Similar experiments using a vomero-
nasal gene cluster deletion demonstrate a complete absence of
cis coexpression, a so-called ‘‘cluster lock’’ (Roppolo et al.,
2007). We see a similar bias, though not a strict lock since cis
coexpression was detected, albeit at low frequency. Thus, the
two systems most likely share common mechanisms. More
pertinent to our present argument, our experiments demonstrate
that the TAAR coexpression bias inDT4-OSNs is not the byprod-
uct of a cluster effect.
The DIII Domain
The previously described DI and DII domains are formed by
afferent projections of OSN types to the olfactory bulb. Our data
suggest that the dorsal TAAR projection, DIII, is similarly gener-
ated. We note that DIII glomeruli are often partially intermingled
with DI glomeruli. Thus, there is not as distinct a ‘‘boundary’’
between DI and DIII glomeruli as there is between DI and DII.
This most likely reflects the fact that the DIII projection comprises
far fewer glomeruli than the other projections. However, like the
other two OSN types, the d3 OSN type appears to possess a
specific axon guidance identity. Preliminary data indicate that
TAAR-expressing OSNs project to the same region of the bulb
even if they are forced to express a class I OR (unpublished
data). Thus, theDIII domainmost likelyarises fromthesamemech-
anisms as DI and DII. Given their close association, DI and DIII
glomeruli may share a similar function, or information from the
two projections may be combined for downstream processing.
Four of the 14 TAAR genes have ventral or broad expression
patterns that are not confined to the dorsal epithelium. Given
what is known about epithelium-to-bulb topography (Schoenfeld
and Cleland, 2005), Taar7a and Taar7b may map to ventral
glomeruli, whereas Taar6 and Taar7d may map to both ventral
and dorsal glomeruli. Alternatively, they could represent an
OSN type with an atypical projection pattern, analogous to the
OR37 family (Strotmann et al., 2000). Interestingly, the DT4 and
DT9 strains reported here, as well as taggedDT5 andDT6 strains
(data not shown), exhibit spurious projections to glomeruli that
are more caudal and ventral than DIII. This suggests that
Taar6, 7a, 7b, and/or 7dmay project to more ventral and caudal
glomeruli. In any case, our data indicate that all three known
classes of mammalian ORs are systematically mapped on the
dorsal surface of the bulb.
Amine Responses in the Dorsal Olfactory Bulb
Few studies have characterized responses to amines in the
mammalian olfactory bulb, perhaps due to their generally offen-
sive odor. Previous data show that the amines activate broad
regions of the rodent olfactory bulb (Ma et al., 2012; Takahashi
et al., 2004). One previous study in the rat found that amines
activate a set of anterior, dorsal glomeruli that also responds to
carboxylic acids and aldehydes, as well as a cluster of caudal
amine-selective glomeruli (Takahashi et al., 2004). Our data
suggest that the observed amine-selective cluster may corre-
spond to the TAARs. In our experiments, amine responses
were restricted to the DIII region, except at high concentrations,
which could elicit activation in the DI region as well (data not
shown). Therefore, the broader amine responses in previous
studies were likely due to the higher stimulus concentrations
used (100- to 1,000-fold higher than those used here). The
data also suggest that the organization of dorsal TAAR pro-
jections may be similar in rats and mice.The DIII glomeruli were by far the most sensitive in the dorsal
bulb to the tested amines, though glomeruli outside the DIII
cluster were also amine responsive. One obvious limitation of
our experiments is that the imaging is limited to the dorsal
bulb. It is therefore unclear whether there are also ventral
glomeruli with comparable sensitivity to amines. Future studies
mapping odorant responses in the ventral bulb and character-
izing sensory thresholds in the TAAR cluster deletion mice may
shed light on this issue.
In addition, it is unclear whether the DIII glomeruli are activated
exclusively by amines or whether they respond to other classes
of compounds. Our imaging data support the idea that TAARs
respond preferentially to amines (Liberles and Buck, 2006).
However, responses to nonamines might be seen if enough
odorants are tested, consistent with a lack of chemotopy in the
olfactory bulb (Bozza et al., 2004; Ma et al., 2012; Soucy et al.,
2009). Regardless, from our perspective, the important question
is not whether the DIII domain is activated solely by amines, but
whether selective activation of the DIII glomeruli relays specific
information that is relevant for certain olfactory behaviors.
Function of the TAARs
The functional significance of the dorsal domains, including DIII,
is unclear. Odorants associated with decay and fermentation,
such as short chain carboxylic acids, preferentially activate DI
(Bozza et al., 2009; Kobayakawa et al., 2007; Matsumoto
et al., 2010; Takahashi et al., 2004). Similarly, we find that
amines, which are byproducts of tissue decomposition (Silla
Santos, 1996) and have a repulsive odor to humans, preferen-
tially activate DIII. It has been suggested that the dorsal bulb
may mediate innate aversion in rodents (Kobayakawa et al.,
2007; Matsumoto et al., 2010), and both acids and amines
have been reported as aversive stimuli in mice, albeit at
extremely high concentrations (Kobayakawa et al., 2007). Simi-
larly, the T4 ligand b-phenylethylamine, which is enriched in
predator cat urine, has been reported to elicit innate aversion
in rats and mice (Ferrero et al., 2011). It is tempting to speculate
that selective activation of the DIII domain may represent the
aversive quality of amines.
The TAAR repertoire is evolutionarily retained in mammals,
suggesting that it serves a critical function in olfaction that is
not met by the much larger repertoire of canonical ORs. One
view is that TAARs selectively encode information about
pheromones (Liberles, 2009; Munger et al., 2009), socially
relevant odors, orpredator-derivedcues (Ferreroet al., 2011; Lib-
erles and Buck, 2006). Our data suggest an alternate (though not
mutually exclusive) view—that this phylogenetically distinct class
of aminergic receptors is simply required for high-sensitivity
detection of amines. In some species, such as rodents, the
TAAR inputs may feed into circuits that elicit innate avoidance
or context-specific behaviors. But, more generally, the small
TAAR familymay contribute significantly to setting the behavioral
thresholds of animals to a subset of olfactory stimuli.
EXPERIMENTAL PROCEDURES
All procedures were carried out in accordance with the National Institutes of
Health (NIH) Guide for the Care and Use of Laboratory Animals and wereCell Reports 2, 76–88, July 26, 2012 ª2012 The Authors 85
approved by the Northwestern University Institutional Animal Care and Use
Committee.
Gene Targeting
Gene targeting to modify TAAR alleles via homologous recombination was
performed as described previously (Bozza et al., 2009), with some modifica-
tions. Genomic fragments containing TAAR loci originated from 129S7 BAC
clones (Adams et al., 2005; bMQ-215O19 for Taar3 and Taar4, bMQ-329H19
for Taar9). BAC recombineering (Warming et al., 2005) was used to insert
AscI-flanked selection cassettes (galK or kan) into the targeted loci on the
BACs just downstream of the TAAR coding sequences. Targeting vectors
were then isolated by gap-repair, and the selection cassettes replaced with
marker cassettes by standard cloning. See Extended Experimental Proce-
dures for detailed cloning information for the six gene targeted alleles
described here.
Targeting vectors were linearized and electroporated into 129 or 129B6F1
embryonic stem cells, and G418-resistant clones were screened by long-
range PCR and/or Southern blotting. Chimeras were generated by
aggregation of embryonic stem cells with CD1 morulae (Wood et al., 1993)
or by injection into C57BL/6 blastocysts. Chimeras were crossed to C57BL/
6 females, and all strains were on a mixed 129/B6 background.
The TAAR cluster deletion (DT2-9) was generated by Cre-mediated trans-
allelic recombination in vivo (Wu et al., 2007). See Extended Experimental
Procedures.
In Situ Hybridization and Immunohistochemistry
The combination of in situ hybridization and immunohistochemistry was
performed as described previously (Bozza et al., 2009; Ishii et al., 2004),
with minor modifications (see also Extended Experimental Procedures).
TAAR coding-sequence probes were transcribed directly from T7-tagged
PCR products that were amplified from the genomic BAC clones. Gene-
specific probes for individual members of the Taar7 and Taar8 subfamilies
were generated to 30 UTR sequence obtained by PCR from a cDNA library
of olfactory epithelium. These 30 UTR probes (<1 kb) were hybridized at
55C and washed at 59C. The standard coding-sequence probes (1 kb)
were hybridized at 62C and washed at 65C. The single probes and probe
mixes for class I and class II dorsal ORs were as previously described (Bozza
et al., 2009). The probe mix for TAARs comprised Taar2, Taar3, Taar4, Taar5,
and Taar9. The ‘‘all-TAARs’’ probe mix comprised all nine coding-sequence
probes. See Table S1 for probe target sequences.
In Vivo Imaging
Imaging was performed as described previously (Bozza et al., 2004), with the
following modifications. Mice were 5–12 weeks old and were heterozygous
for both the OMP-spH and DT4-YFP alleles. Mice were anesthetized with
sodium pentobarbital (65mg/kg; Sigma) and given atropine sulfate (5.4 mg/kg;
Med-Pharmex); chlorprothixene hydrochloride (13 mg/kg; Sigma) as a seda-
tive; and pyridoxalphosphate-6-azophenyl-20, 40-disulfonic acid (PPADS)
and suramin (51 mg/kg and 130 mg/kg; Tocris) to counteract effects of nasal
inflammation (Hegg and Lucero, 2006). A double tracheotomy was performed
so that animals could breathe freely while odor delivery via artificial sniffing
was controlled through the forward tube (Wachowiak and Cohen, 2001).
The bone overlying the olfactory bulbs was thinned using a dental drill. Light
excitation was provided using a 200 W metal-halide lamp (Prior Scientific)
filtered through standard filters sets for YFP (86001 JP3, Chroma) and GFP
(96343, Nikon). Optical signals for synaptopHluorin were recorded using a
CCD camera (NeuroCCD SM256; RedShirtImaging) at 7 Hz for 10 s, which
included a 2 s prestimulus interval and a 2 s odor pulse. Interstimulus interval
was at least 120 s. Artificial sniffing during the stimulus period was 150 ml/min
at 3 Hz. Odorants were delivered using a computer-controlled, flow dilution
olfactometer that delivered nitrogen and purified air to a Teflon mixing
chamber/odor port. Disposable odor cartridges were attached directly to
this port. This design was required to prevent contamination of the olfactom-
eter with even low concentrations of amines. Blank trials between odor stimuli
were compared throughout the experiment to monitor potential odorant
contamination in the nasal passages. In order to obtain low enough concentra-
tions, amines were typically diluted 1:100 or 1:1,000 in water, then further by86 Cell Reports 2, 76–88, July 26, 2012 ª2012 The Authorsflow dilution. Vapor concentrations were calculated using published vapor
pressures (US EPA, Estimation Programs Interface Suite, v 4.0).
To control for photobleaching, blank trials were subtracted from odor trials
prior to analysis. Response maps were obtained by subtracting a 1.4 s
temporal average preceding the stimulus from a 1.4 s temporal average at
the end of the trial. Responses are expressed as DF to account for the fact
that the background spH fluorescence is not correlated with the pool of indi-
cator that reports neuronal activity (Bozza et al., 2004; McGann et al., 2005).
Max response images were produced by projecting maximum pixel values
across individual responses onto a single image. Stimuli were presented at
least twice, but data were often taken from the first trial, as rundown of the
amine responses was prevalent. Images were processed and analyzed in
Neuroplex (RedShirtImaging) and Image J (NIH) software.
Individual glomerular responses for hierarchical cluster analysis were ob-
tained by drawing regions of interest (ROIs) around YFP-positive, amine-
responsive glomeruli. Responses were thresholded at 2 SD from background
noise (measured from multiple nonresponsive regions) and scaled to the
maximum response of each glomerulus for clustering analysis.
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